Cer(d18:1/20:0)
|
Basic information |
| Metabolite name | Cer(d18:1/20:0) |
 | HMDB0004951 |
 |
C00195 |
 |
5283566 |
| Synonyms | Ceramide (d18:1/20:0) |
| No. of studies | 4 |
|
Basic information |
| Metabolite name | Cer(d18:1/20:0) |
| HMDB0004951 |
|
C00195 |
|
5283566 |
| Synonyms | Ceramide (d18:1/20:0) |
| No. of studies | 4 |
|
Relationship between Cer(d18:1/20:0) and depression (count: 4) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M122 | Type3 | maprotiline group vs. control group | Prefrontal cortex | BALB/c mouse | Up |
| Study M122 | Type3 | paroxetine group vs. control group | Prefrontal cortex | BALB/c mouse | Up |
| Study M712 | Type1 | depression group vs. control group | Faece | Cynomolgus monkey | Up |
| Study M908 | Type3 | post-ketamine treatment vs. baseline | Plasma | Human | Down |
| Study M962 | Type2 | 24h-post ketamine infusion vs. baseline | Plasma | Human | Up |